Runyi Ye

413 total citations
15 papers, 306 citations indexed

About

Runyi Ye is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Runyi Ye has authored 15 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Runyi Ye's work include Ubiquitin and proteasome pathways (4 papers), interferon and immune responses (3 papers) and MicroRNA in disease regulation (3 papers). Runyi Ye is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), interferon and immune responses (3 papers) and MicroRNA in disease regulation (3 papers). Runyi Ye collaborates with scholars based in China. Runyi Ye's co-authors include Nan Shao, Yawei Shi, Yunjian Zhang, Ying Lin, Lingxiao Pan, Yongbo Huang, Shenming Wang, Caisheng Ye, Yang Zhao and Shenming Wang and has published in prestigious journals such as Life Sciences, Cancer Letters and Journal of Vascular Surgery.

In The Last Decade

Runyi Ye

15 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Runyi Ye China 12 192 142 66 45 39 15 306
Helena Nord Sweden 13 212 1.1× 102 0.7× 58 0.9× 47 1.0× 18 0.5× 19 364
Xiaochuang Feng China 7 216 1.1× 139 1.0× 71 1.1× 48 1.1× 26 0.7× 16 310
Jinfeng Gan China 10 203 1.1× 91 0.6× 98 1.5× 47 1.0× 26 0.7× 21 324
Xianle Shi China 6 194 1.0× 78 0.5× 76 1.2× 46 1.0× 38 1.0× 10 311
Chaojie Wang United States 9 192 1.0× 46 0.3× 64 1.0× 35 0.8× 38 1.0× 14 325
Atsutaka Masuda Japan 9 142 0.7× 92 0.6× 85 1.3× 51 1.1× 10 0.3× 19 279
Yingji Chen China 9 223 1.2× 127 0.9× 48 0.7× 84 1.9× 36 0.9× 26 344
Linlin Mao China 10 122 0.6× 62 0.4× 79 1.2× 41 0.9× 20 0.5× 27 228

Countries citing papers authored by Runyi Ye

Since Specialization
Citations

This map shows the geographic impact of Runyi Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runyi Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runyi Ye more than expected).

Fields of papers citing papers by Runyi Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Runyi Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runyi Ye. The network helps show where Runyi Ye may publish in the future.

Co-authorship network of co-authors of Runyi Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Runyi Ye. A scholar is included among the top collaborators of Runyi Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Runyi Ye. Runyi Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Li, Tianfu, et al.. (2022). KIF17 maintains the epithelial phenotype of breast cancer cells and curbs tumour metastasis. Cancer Letters. 548. 215904–215904. 2 indexed citations
3.
Jian, Yunting, Hongyi Xu, Yawei Shi, et al.. (2022). Protein phosphatase 1 regulatory inhibitor subunit 14C promotes triple‐negative breast cancer progression via sustaining inactive glycogen synthase kinase 3 beta. Clinical and Translational Medicine. 12(1). e725–e725. 14 indexed citations
4.
Ye, Runyi, Huijuan Zeng, Nan Shao, et al.. (2021). Tripartite motif-containing 3 (TRIM3) enhances ER signaling and confers tamoxifen resistance in breast cancer. Oncogenesis. 10(9). 60–60. 10 indexed citations
5.
Ye, Runyi, Dongwei Liu, Hongyu Guan, et al.. (2021). AHNAK2 promotes thyroid carcinoma progression by activating the NF-κB pathway. Life Sciences. 286. 120032–120032. 16 indexed citations
6.
Li, Tianfu, Runyi Ye, Jiong Bi, et al.. (2021). LncRNA LGALS8-AS1 Promotes Breast Cancer Metastasis Through miR-125b-5p/SOX12 Feedback Regulatory Network. Frontiers in Oncology. 11. 12 indexed citations
7.
Guo, Yan, Hai Li, Guohong Wei, et al.. (2019). Long Noncoding RNA LOC100129940-N Is Upregulated in Papillary Thyroid Cancer and Promotes the Invasion and Progression. International Journal of Endocrinology. 2019. 1–12. 11 indexed citations
8.
Lian, Rong, Jingjing Zhao, Runyi Ye, et al.. (2019). IGFBP7 inhibits cell proliferation by suppressing AKT activity and cell cycle progression in thyroid carcinoma. Cell & Bioscience. 9(1). 44–44. 25 indexed citations
9.
Shi, Yawei, Yang Zhao, Yunjian Zhang, et al.. (2018). AFF3 upregulation mediates tamoxifen resistance in breast cancers. Journal of Experimental & Clinical Cancer Research. 37(1). 254–254. 27 indexed citations
10.
Shi, Yawei, Yang Zhao, Yunjian Zhang, et al.. (2018). TNNT1 facilitates proliferation of breast cancer cells by promoting G1/S phase transition. Life Sciences. 208. 161–166. 33 indexed citations
11.
Guan, Hongyu, Yan Guo, Liehua Liu, et al.. (2018). INAVA promotes aggressiveness of papillary thyroid cancer by upregulating MMP9 expression. Cell & Bioscience. 8(1). 26–26. 17 indexed citations
12.
Shi, Yawei, Yang Zhao, Nan Shao, et al.. (2017). Overexpression of microRNA-96-5p inhibits autophagy and apoptosis and enhances the proliferation, migration and invasiveness of human breast cancer cells. Oncology Letters. 13(6). 4402–4412. 49 indexed citations
13.
Zhou, Mengli, Jie Li, Zhanqiang Zhang, et al.. (2016). RING1 and YY1 binding protein suppresses breast cancer growth and metastasis. International Journal of Oncology. 49(6). 2442–2452. 23 indexed citations
14.
Huang, Yongbo, Lingxiao Pan, Runyi Ye, et al.. (2013). Expressions of miRNAs in papillary thyroid carcinoma and their associations with the BRAFV600E mutation. European Journal of Endocrinology. 168(5). 675–681. 39 indexed citations
15.
Ye, Caisheng, Lingxiao Pan, Yongbo Huang, et al.. (2011). Somatic mutations in exon 17 of the TEK gene in vascular tumors and vascular malformations. Journal of Vascular Surgery. 54(6). 1760–1768.e3. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helena Nord Breakdown of academic impact, for papers by Xiaochuang Feng Breakdown of academic impact, for papers by Jinfeng Gan Breakdown of academic impact, for papers by Xianle Shi Breakdown of academic impact, for papers by Chaojie Wang Breakdown of academic impact, for papers by Atsutaka Masuda Breakdown of academic impact, for papers by Yingji Chen Breakdown of academic impact, for papers by Linlin Mao
Rankless by CCL
2026